Doppler Image

Marketplace Links

Social Links

Main Menu

WRAL.com 30
Markets
Stocks
Mutual Funds & ETF's
Sectors
Rates
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Local Stocks
Threshold Jointly Develops TH-302 With Merck
By: MarketMinute.com Stock News
Posted on February 03, 2012 at 13:51 PM EST

Threshold Pharmaceuticals Inc. (Nasdaq: THLD) and Merck will jointly develop and commercialize Threshold's cancer treatment TH-302. Shares of Threshold more than doubled by leaping $1.39 to $2.68.



Related Stocks:
Threshold Pharmaceuticals, Inc.
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Mortgage Rates, CD Rates & Home Equity Rates provided by Banks.com
Press Release Service provided by PRConnect.
Fundamental data supplied by Morningstar
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
advertisement